Concepedia

Bart Heeg

BH

Statistics

Publications

24

Citations

663

H-Index

18

Active since

2005

Affiliations

Pharmerit (Netherlands)(Current)

University of Groningen

University Medical Center Groningen

Janssen (Belgium)

Pfizer (United States)

Bart Heeg is an author at Pharmerit (Netherlands) specializing in pharmacoeconomics, pharmacy, and cost-effectiveness analysis.

Publications per year

2005–2023

24

Publications

24

Costs and effects of long-acting risperidone compared with oral atypical and conventional depot formulations in Germany

Gerd Laux, Bart Heeg, Ben A. van Hout et al. · PharmacoEconomics · 2005 · 65 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +8

Modelling the impact of compliance on the costs and effects of long-acting risperidone in Canada

Pierre Chue, Bart Heeg, Erik Buskens et al. · PharmacoEconomics · 2005 · 49 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +8

Modelling Approaches

Bart Heeg, Joep Damen, Erik Buskens et al. · PharmacoEconomics · 2008 · 47 citations

Modelling the treated course of schizophrenia: Development of a discrete event simulation model

Bart Heeg, Erik Buskens, Martín Knapp et al. · PharmacoEconomics · 2005 · 44 citations

Medicine, Psychiatry, Mental Health Care +11

Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs

I. van Oostrum, Mario Ouwens, Antonio Remiro‐Azócar et al. · Value in Health · 2021 · 44 citations · Full text

Public Health, Biostatistics, Oncology +14

1–5 of 24